4167
松瑞藥
-0.15 (-0.79%)18.95474成交張數5.71本益比1.34股價淨值比7.83%殖利率2026-09-11資料日期
毛利率、營業利益率、淨利率
單季;近十年
單季營收
億元
| 季度 | 營收(億) | 營收年增 | 毛利(億) | 毛利率 | 營業利益(億) | 營業利益率 | 淨利率 |
|---|---|---|---|---|---|---|---|
| 2026Q2 | 2.9 | -14.8% | 1.0 | 36.7% | 0.2 | 5.5% | 270.2% |
| 2026Q1 | 2.3 | -11.5% | 0.7 | 31.0% | 0.2 | 8.2% | 38.6% |
| 2025Q4 | 3.2 | 15.5% | 1.0 | 30.1% | 0.3 | 9.6% | 27.6% |
| 2025Q3 | 2.8 | -15.0% | 1.0 | 35.9% | 0.4 | 15.2% | 28.3% |
| 2025Q2 | 3.4 | -3.8% | 1.3 | 38.2% | 0.8 | 24.4% | -5.1% |
| 2025Q1 | 2.6 | 1.8% | 1.0 | 36.9% | 0.3 | 10.1% | 146.3% |
| 2024Q4 | 2.8 | -12.9% | 0.8 | 29.6% | 0.2 | 6.2% | 16.9% |
| 2024Q3 | 3.3 | 15.8% | 1.2 | 37.3% | 0.7 | 22.2% | 12.8% |
| 2024Q2 | 3.5 | 56.3% | 0.9 | 24.9% | 0.3 | 8.8% | 6.3% |
| 2024Q1 | 2.6 | 16.8% | 0.5 | 20.7% | -0.0 | -1.2% | 27.4% |
| 2023Q4 | 3.2 | 25.1% | 1.3 | 41.6% | 0.8 | 24.9% | 13.9% |
| 2023Q3 | 2.9 | -17.5% | 0.1 | 2.3% | -0.5 | -17.1% | -5.7% |
| 2023Q2 | 2.2 | -37.3% | 0.3 | 12.9% | -0.3 | -12.8% | 2.3% |
| 2023Q1 | 2.2 | -27.8% | 0.5 | 24.0% | -0.0 | -1.8% | -1.2% |
| 2022Q4 | 2.5 | -24.2% | 0.3 | 11.9% | -0.2 | -8.2% | -16.0% |
| 2022Q3 | 3.5 | -8.2% | 0.4 | 12.8% | -0.1 | -3.5% | 38.1% |
| 2022Q2 | 3.6 | -32.0% | 0.5 | 14.8% | -0.0 | -0.8% | -0.4% |
| 2022Q1 | 3.1 | -39.3% | 0.0 | 1.2% | -0.6 | -19.1% | -17.6% |
| 2021Q4 | 3.4 | -40.9% | 0.3 | 8.0% | -0.3 | -8.0% | -8.8% |
| 2021Q3 | 3.8 | -11.7% | 0.2 | 4.0% | -0.6 | -16.8% | -15.0% |
| 2021Q2 | 5.2 | 30.3% | 1.1 | 21.2% | 0.3 | 6.6% | 3.1% |
| 2021Q1 | 5.1 | 17.9% | 1.5 | 30.6% | 0.9 | 16.8% | 15.8% |
| 2020Q4 | 5.7 | 50.9% | 1.9 | 33.7% | 1.1 | 19.0% | 16.1% |
| 2020Q3 | 4.3 | 25.7% | 1.3 | 30.6% | 0.6 | 14.1% | 10.5% |
| 2020Q2 | 4.0 | 32.1% | 1.1 | 27.0% | 0.3 | 8.6% | 5.7% |
| 2020Q1 | 4.3 | 44.3% | 1.3 | 29.8% | 0.3 | 6.5% | 21.3% |
| 2019Q4 | 3.8 | 50.0% | 1.4 | 36.1% | 0.7 | 17.4% | 11.0% |
| 2019Q3 | 3.4 | 31.0% | 0.9 | 27.5% | 0.1 | 3.1% | 0.6% |
| 2019Q2 | 3.0 | -2.9% | 0.6 | 18.3% | -0.2 | -8.1% | -11.4% |
| 2019Q1 | 3.0 | 6.2% | 0.7 | 22.2% | 0.0 | 1.2% | -4.5% |
| 2018Q4 | 2.5 | -21.6% | -0.1 | -3.8% | -1.1 | -44.0% | -44.9% |
| 2018Q3 | 2.6 | -33.0% | -0.4 | -17.2% | -0.9 | -35.4% | -37.1% |
| 2018Q2 | 3.1 | -29.4% | 0.0 | 1.1% | -0.6 | -20.5% | -16.7% |
| 2018Q1 | 2.8 | -39.9% | -0.2 | -7.0% | -0.8 | -29.6% | -35.0% |
| 2017Q4 | 3.2 | -33.7% | 0.5 | 14.9% | -0.3 | -9.6% | -16.7% |
| 2017Q3 | 3.9 | -4.9% | 1.1 | 28.8% | 0.2 | 5.7% | 4.3% |
| 2017Q2 | 4.4 | 27.8% | 1.6 | 36.5% | 0.7 | 16.7% | 10.3% |
| 2017Q1 | 4.7 | 58.5% | 1.2 | 25.5% | 0.4 | 8.6% | 2.8% |
| 2016Q4 | 4.8 | – | 1.2 | 24.4% | 0.2 | 3.8% | 4.1% |
| 2016Q3 | 4.1 | – | 0.5 | 11.8% | -0.4 | -9.6% | -11.9% |